Current developments of gene therapy in human diseases

被引:2
作者
Liu, Fanfei [1 ]
Li, Ruiting [2 ]
Zhu, Zilin [3 ]
Yang, Yang [1 ,2 ]
Lu, Fang [1 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Ophthalmol, Chengdu, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China
[3] Sichuan Univ, Coll Life Sci, Chengdu, Sichuan, Peoples R China
来源
MEDCOMM | 2024年 / 5卷 / 09期
基金
中国国家自然科学基金;
关键词
AAV; clinical trials; CRISPR-Cas; gene therapy; human diseases; DUCHENNE MUSCULAR-DYSTROPHY; MACULAR DEGENERATION; OPEN-LABEL; PARKINSONS-DISEASE; IN-VIVO; VORETIGENE NEPARVOVEC; AUREUS CRISPR-CAS9; IMMUNE-RESPONSES; RECOMBINANT AAV; HEART-FAILURE;
D O I
10.1002/mco2.645
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Gene therapy has witnessed substantial advancements in recent years, becoming a constructive tactic for treating various human diseases. This review presents a comprehensive overview of these developments, with a focus on their diverse applications in different disease contexts. It explores the evolution of gene delivery systems, encompassing viral (like adeno-associated virus; AAV) and nonviral approaches, and evaluates their inherent strengths and limitations. Moreover, the review delves into the progress made in targeting specific tissues and cell types, spanning the eye, liver, muscles, and central nervous system, among others, using these gene technologies. This targeted approach is crucial in addressing a broad spectrum of genetic disorders, such as inherited lysosomal storage diseases, neurodegenerative disorders, and cardiovascular diseases. Recent clinical trials and successful outcomes in gene therapy, particularly those involving AAV and the clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated proteins, are highlighted, illuminating the transformative potentials of this approach in disease treatment. The review summarizes the current status of gene therapy, its prospects, and its capacity to significantly ameliorate patient outcomes and quality of life. By offering comprehensive analysis, this review provides invaluable insights for researchers, clinicians, and stakeholders, enriching the ongoing discourse on the trajectory of disease treatment. Gene therapy has seen remarkable advancements in recent decades, demonstrating its immense potential in treating a wide range of genetic and acquired diseases. Several AAV gene therapy products have been introduced to the market, addressing various conditions. This review explores the clinical applications of AAV in major human diseases, including ocular diseases, neuromuscular diseases, hematological diseases, neurological diseases, cardiovascular diseases, and lysosomal storage diseases. image
引用
收藏
页数:30
相关论文
共 215 条
  • [1] A cytosine deaminase for programmable single-base RNA editing
    Abudayyeh, Omar O.
    Gootenberg, Jonathan S.
    Franklin, Brian
    Koob, Jeremy
    Kellner, Max J.
    Ladha, Alim
    Joung, Julia
    Kirchgatterer, Paul
    Cox, David B. T.
    Zhang, Feng
    [J]. SCIENCE, 2019, 365 (6451) : 382 - +
  • [2] RNA targeting with CRISPR-Cas13
    Abudayyeh, Omar O.
    Gootenberg, Jonathan S.
    Essletzbichler, Patrick
    Han, Shuo
    Joung, Julia
    Belanto, Joseph J.
    Verdine, Vanessa
    Cox, David B. T.
    Kellner, Max J.
    Regev, Aviv
    Lander, Eric S.
    Voytas, Daniel F.
    Ting, Alice Y.
    Zhang, Feng
    [J]. NATURE, 2017, 550 (7675) : 280 - +
  • [3] Spliced: Boundary-work and the establishment of human gene therapy
    Addison, Courtney
    [J]. BIOSOCIETIES, 2017, 12 (02) : 257 - 281
  • [4] Non-viral delivery of CRISPR-Cas9 complexes for targeted gene editing via a polymer delivery system
    Ahern, Jonathan O'Keeffe
    Lara-Saez, Irene
    Zhou, Dezhong
    Murillas, Rodolfo
    Bonafont, Jose
    Mencia, Angeles
    Garcia, Marta
    Manzanares, Dario
    Lynch, Jennifer
    Foley, Ruth
    Xu, Qian
    Sigen, A.
    Larcher, Fernando
    Wang, Wenxin
    [J]. GENE THERAPY, 2022, 29 (3-4) : 157 - 170
  • [5] Rod-Derived Cone Viability Factor Promotes Cone Survival by Stimulating Aerobic Glycolysis
    Ait-Ali, Najate
    Fridlich, Ram
    Millet-Puel, Geraldine
    Clerin, Emmanuelle
    Delalande, Francois
    Jaillard, Celine
    Blond, Frederic
    Perrocheau, Ludivine
    Reichman, Sacha
    Byrne, Leah C.
    Olivier-Bandini, Anne
    Bellalou, Jacques
    Moyse, Emmanuel
    Bouillaud, Frederic
    Nicol, Xavier
    Dalkara, Deniz
    van Dorsselaer, Alain
    Sahel, Jose-Alain
    Leveillard, Thierry
    [J]. CELL, 2015, 161 (04) : 817 - 832
  • [6] Niosome-Based Approach for In Situ Gene Delivery to Retina and Brain Cortex as Immune-Privileged Tissues
    Al Qtaish, Nuseibah
    Gallego, Idoia
    Villate-Beitia, Ilia
    Sainz-Ramos, Myriam
    Lopez-Mendez, Tania Belen
    Grijalvo, Santiago
    Eritja, Ramon
    Soto-Sanchez, Cristina
    Martinez-Navarrete, Gema
    Fernandez, Eduardo
    Puras, Gustavo
    Pedraz, Jose Luis
    [J]. PHARMACEUTICS, 2020, 12 (03)
  • [7] Aleman Tomas S, 2022, Ophthalmology, V129, P1177, DOI 10.1016/j.ophtha.2022.06.006
  • [8] X-linked myotubular myopathy A prospective international natural history study
    Annoussamy, Melanie
    Lilien, Charlotte
    Gidaro, Teresa
    Gargaun, Elena
    Che, Virginie
    Schara, Ulrike
    Gangfuss, Andrea
    D'Amico, Adele
    Dowling, James J.
    Darras, Basil T.
    Daron, Aurore
    Hernandez, Arturo
    de lattre, Capucine
    Arnal, Jean-Michel
    Mayer, Michele
    Cuisset, Jean-Marie
    Vuillerot, Carole
    Fontaine, Stephanie
    Bellance, Remi
    Biancalana, Valerie
    Buj-Bello, Ana
    Hogrel, Jean-Yves
    Landy, Hal
    Servais, Laurent
    [J]. NEUROLOGY, 2019, 92 (16) : E1852 - E1867
  • [9] Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors
    Anzalone, Andrew V.
    Koblan, Luke W.
    Liu, David R.
    [J]. NATURE BIOTECHNOLOGY, 2020, 38 (07) : 824 - 844
  • [10] Search-and-replace genome editing without double-strand breaks or donor DNA
    Anzalone, Andrew V.
    Randolph, Peyton B.
    Davis, Jessie R.
    Sousa, Alexander A.
    Koblan, Luke W.
    Levy, Jonathan M.
    Chen, Peter J.
    Wilson, Christopher
    Newby, Gregory A.
    Raguram, Aditya
    Liu, David R.
    [J]. NATURE, 2019, 576 (7785) : 149 - +